Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.10474 | 5 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.10845 | 6 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.10199 | 6 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.07233 | 6 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.09192 | 6 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.13577 | 5 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.13273 | 6 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.08388 | 6 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.08175 | 6 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.25682 | 11 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.26938 | 11 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.08664 | 6 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.10512 | 6 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.09695 | 6 |